Heba Talat Mahmoud

  • Citations Per Year
Learn More
OBJECTIVE Significant and balanced pulmonary artery (PA) growth following arterial duct (AD) stenting has already been reported in literature. However, no data are so far available about the role of this percutaneous approach in promoting PA growth in the case of congenital heart disease (CHD) with completely duct-dependent pulmonary blood flow (CDD-PBF).(More)
Post-myocardial infarction (MI) ventricular septal defects (VSD) are a rare but life-threatening complication of acute MI, with very high mortality rates even if timely approached by surgical repair. Transcatheter closure is an attractive alternative to surgery. However, this option is currently deemed challenging and often unsuitable in complex VSD. We(More)
Significant and balanced PA growth following arterial duct (AD) stenting has already been consistently reported in literature. However, to date, no data are available about the role of this approach as palliation of congenital heart disease with a duct-dependent discontinuous pulmonary artery (dPA). The aim of this study was to evaluate the fate of a dPA of(More)
A 45-year-old man with tricuspid valve Ebstein anomaly, submitted for surgical repair by plication of the atrialized part of the right ventricle (RV) and tricuspid valve replacement with a 31-mm biologic prosthesis (Carpentier-Edwards porcine, Baxter Healthcare Corp., Edwards Division; Santa Ana, California, USA) at the age of 14 years, was referred because(More)
OBJECTIVE To report our experience on novel, off-label use of Amplatzer Duct Occluder type II additional sizes (ADO II-AS) device (St. Jude Medical, Inc.; St. Paul, Minnesota, USA) to manage nonduct shunt lesions. METHODS AND RESULTS Among the 114 patients submitted to ADO II-AS implantation at our institution, 12 received this device as off-label(More)
OBJECTIVES This study aimed to report a large, single-center experience of percutaneous arterial duct (AD) closure using Amplatzer Duct Occluder II Additional Sizes device (ADO II-AS)(St. Jude Medical Corp, St. Paul, MN, USA). BACKGROUND Transcatheter closure of AD remains challenging in low body weight patients and those who have a persisting shunt(More)
  • 1